R. G. Wasson, A New Mexican Psychotropic Drug from the Mint Family, Bot. Mus. Leafl

B. Clebsch, C. D. Barner, I. Valdés, L. J. Díaz, J. Paul et al., The new book of salvias. 2e éd Ethnopharmacology of ska Maria Pastora (Salvia divinorum, J. Ethnopharmacol, vol.74, pp.344-347, 1983.

T. Munro, The Chemistry of Salvia divinorum, Thèse de doctorat, pp.283-288, 2006.

E. K. Perry, H. Ashton, and A. H. Young, Neurochemistry of consciousness: neurotransmitters in mind, pp.344-350, 2002.
DOI : 10.1075/aicr.36

J. Moss, Salvia slips into our consciousness . The Vancouver Sun, 2003.

R. Marushia, Salvia divinorum: The Botany, Ethnobotany, Biochemistry and Future of a Mexican Mint, 2003.

I. Valdés and L. J. , The early history of Salvia divinorum. Entheogen Rev, pp.73-7580, 2001.

D. Stuart, Dangerous garden: the quest for plants to change our lives". Cambridge, pp.208-218, 2004.

D. J. Siebert, The History of the First Salvia divinorum Plants Cultivated Outside of Mexico

J. B. Johnson, Some notes on the Mazatec, Revista Mexicana de Estudios Antropológicos, vol.3, pp.142-156, 1939.

G. Toro, B. Thomas, and J. Ott, Drugs of the Dreaming: Oneirogens: Salvia divinorum and Other Dream-Enhancing Plants". Rochester: Inner Traditions: Salvinorin, a New trans-Neoclerodane Diterpene from Salvia divinorum (Labiatae), J. Chem. Soc., Perkin Trans, vol.1, pp.149-162, 1982.

I. Valdès, . Lj, W. Butler, G. Hatfield, A. Paul et al., Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint, Salvia divinorum, The Journal of Organic Chemistry, vol.49, issue.24, pp.4716-4720, 1984.
DOI : 10.1021/jo00198a026

D. M. Turner, Salvinorin -The Psychedelic Essence of Salvia divinorum [16] SAMHSA. Use of Specific Hallucinogens: 2006. [En ligne]. Disponible sur http, 1996.

J. E. Lange, M. B. Reed, and K. Croff, College student use of Salvia divinorum, Drug and Alcohol Dependence, vol.94, issue.1-3, pp.263-266, 2008.
DOI : 10.1016/j.drugalcdep.2007.10.018

V. Hoover, D. Marlowe, and N. Patapis, Internet access to Salvia divinorum: Implications for policy, prevention, and treatment, KeywordToolExternal. (Page consultée en juin 2011) [20] Schmidt MM, pp.22-27, 2008.
DOI : 10.1016/j.jsat.2007.07.011

C. Epling and C. D. Játiva, A New Species of Salvia from Mexico, pp.75-76, 1962.

I. L. Valdés, The Pharmacognosy of Salvia divinorum (Epling And Játiva-M): an Investigation of Ska María Pastora, pp.49-50, 1983.

I. L. Valdés, G. M. Hatfield, M. Koreeda, and A. G. Paul, Studies ofSalvia divinorum (Lamiaceae), an Hallucinogenic mint from the Sierra Mazateca in Oaxaca, Central Mexico, Economic Botany, vol.4, issue.2, pp.283-291, 1987.
DOI : 10.1007/BF02858975

B. Culture, En ligne] Disponible sur http

D. J. Siebert, Localization of Salvinorin A and Related Compounds in Glandular Trichomes of the Psychoactive Sage, Salvia divinorum, Annals of Botany, vol.93, issue.6, pp.763-771, 2004.
DOI : 10.1093/aob/mch089

T. A. Vortherms and B. L. Roth, Salvinorin A: From Natural Product to Human Therapeutics, Molecular Interventions, vol.6, issue.5
DOI : 10.1124/mi.6.5.7

L. Kutrzeba, D. Ferreira, and J. Zjawiony, Salvinorins J from Salvia divinorum: Mutarotation in the Neoclerodane System, J Nat Prod, issue.7, pp.721361-1363, 2009.

T. Prisinzano and R. Rothman, Salvinorin A Analogs as Probes in Opioid Pharmacology, Chemical Reviews, vol.108, issue.5, pp.1732-1743, 2008.
DOI : 10.1021/cr0782269

I. L. Valdés, K. Tsujikawa, H. Kuwayama, T. Miyaguchi, Y. T. Kanamori et al., Loliolide from Salvia divinorum Determination of salvinorin A and salvinorin B in Salvia divinorum-related products circulated in Japan Asymmetric synthesis of salvinorin A, a potent kappa opioid receptor agonist, 171. [32], pp.2-3, 1986.

M. Nozawa, Y. Suka, and T. Hoshi, Total Synthesis of the Hallucinogenic Neoclerodane Diterpenoid Salvinorin A, Organic Letters, vol.10, issue.7, pp.10-1365, 2008.
DOI : 10.1021/ol800101v

H. Hagiwara, Y. Suka, and T. Nojima, Second-generation synthesis of salvinorin A, Tetrahedron, vol.65, issue.25, pp.65-4820, 2009.
DOI : 10.1016/j.tet.2009.04.053

L. Bérubé, Terminologie de neuropsychologie et de neurologie du comportement. Recherche et réd, pp.176-213, 1991.

P. Magistretti and E. Pralong, Opioanalgésiques et peptides endogènes in Pharmacologie. Des concepts fondamentaux aux applications thérapeutiques. Paris: Frison-Roche et Genève:Slatkine, pp.337-354, 1998.

B. L. Roth, K. Baner, and R. Westkaemper, Salvinorin A: A potent naturally occurring nonnitrogenous ?? opioid selective agonist, Proceedings of the National Academy of Sciences, vol.99, issue.18, pp.11934-11939, 2002.
DOI : 10.1073/pnas.182234399

Y. Wang, K. Tang, and S. Inan, Comparison of Pharmacological Activities of Three Distinct kappa-ligands (Salvinorin A, TRK-820 and 3FLB) on kappa Opioid Receptors in vitro and their Antipruritic and Antinociceptive Activities in vivo, J. Pharmacol. Exp. Ther, vol.31241, pp.220-230, 2005.

Y. Zhang, E. Butelman, and S. Schlussman, Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors, Psychopharmacology, vol.173, issue.3, pp.551-558, 2005.
DOI : 10.1007/s00213-004-2087-0

P. Beerepoot, V. Lam, and B. Luu, Effects of salvinorin A on locomotor sensitization to D2/D3 dopamine agonist quinpirole, Neuroscience Letters, vol.446, issue.2-3, pp.101-104, 2008.
DOI : 10.1016/j.neulet.2008.09.035

Y. Wang, Y. Chen, and W. Xu, 2-methoxymethyl-salvinorin B is a potent kappa opioid receptor agonist with longer-lasting action in vivo than salvinorin A, J Pharmacol Exp Ther, vol.32445, pp.1073-1083, 2008.

. Williams, Cellular and synaptic adaptations mediating opioid dependence

A. Pfeiffer, V. Brantl, and A. Herz, Psychotomimesis mediated by kappa opiate receptors, Science, vol.233, issue.4765, pp.774-776, 1986.
DOI : 10.1126/science.3016896

C. R. Mccurdy, K. J. Sufka, and G. H. Smith, Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist, Pharmacology Biochemistry and Behavior, vol.83, issue.1, pp.109-113, 2006.
DOI : 10.1016/j.pbb.2005.12.011

D. J. Siebert, Salvia divinorum and salvinorin A: new pharmacologic findings, Journal of Ethnopharmacology, vol.43, issue.1
DOI : 10.1016/0378-8741(94)90116-3

M. Baggott, E. Erowid, and F. Erowid, A Survey of Salvia divinorum Users, Erowid Extracts, vol.6, pp.12-14, 2004.

J. Appel and D. Kim-appel, The Rise of a New Psychoactive Agent: Salvia divinorum, International Journal of Mental Health and Addiction, vol.173, issue.3, pp.248-253, 2007.
DOI : 10.1007/s11469-007-9086-4

D. N. Gonzalez, . L. Khey-;-b, ;. Miller, and . Griffin, Chewing Gum Formula for Enhancing Psycho-Spirituality " .-US Patent App The Salvia divinorum User's Guide. [En ligne] Disponible sur http://sagewisdom.org/usersguide.htmlSalvia divinorum use among a college student sample, Journal of Drug Education, vol.53, issue.383, pp.297-306, 2008.

L. T. Wu-;-g, ;. H. Woody, . G. Li-;-d, F. Blazer, . Ministere et al., Recent national trends in Salvia divinorum use and substance-use disorders among recent and former Salvia divinorum users compared with nonusers " . Substance Abuse and Rehabilitation, pp.2-56, 2011.

. Disponible-sur-http, drogues-info-service.fr/?Salvia-divinorum (page consultée le 15, 2011.

A. Taïrou, M. Gandilhon, and A. Toufik, Phénomènes émergents liés aux drogues en Huitième rapport national du dispositif TRENDDetermination of Salvinorin A and Salvinorin B in Salvia divinorum-Related Products Circulated in Japan, Cinquième rapport national du dispositif TREND Drugs and Chemicals of Concern -SALVIA DIVINORUM, pp.54-105, 2004.

A. A. Salvinorin, Disponible sur http, p.6, 2011.

K. R. Hanes, Antidepressant Effects of the Herb Salvia Divinorum: A Case Report, Journal of Clinical Psychopharmacology, vol.21, issue.6
DOI : 10.1097/00004714-200112000-00025

M. Hamilton, A RATING SCALE FOR DEPRESSION, Journal of Neurology, Neurosurgery & Psychiatry, vol.23, issue.1, pp.56-62, 1960.
DOI : 10.1136/jnnp.23.1.56

S. A. Rovinsky and G. R. Cizadlo, Salvia divinorum Epling et Játiva-M. (Labiatae): An Ethnopharmacological Investigation. The McNair Scholarly Review, pp.142-156, 1998.

R. Capasso, F. Borrelli, and J. Zjawiony, The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A reduce inflammation-induced hypermotility in mice, Neurogastroenterology & Motility, vol.4, issue.0, pp.142-148, 2008.
DOI : 10.1053/j.gastro.2005.06.018

J. Fichna, R. Schicho, and C. Andrews, Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating ??-opioid and cannabinoid receptors, Neurogastroenterology & Motility, vol.41, issue.Suppl. 2, pp.1326-128, 2009.
DOI : 10.1111/j.1365-2982.2009.01369.x

P. L. Beck, J. K. Zjawiony, W. K. Macnaughton, and M. A. Storr, Differential effects of salvinorin A on endotoxin-induced hypermotility and neurogenic ion transport in mouse ileum, Neurogastroenterol Motil, vol.2371, issue.6, pp.583-212, 2011.

E. Butelman, S. Rus, and D. Simpson, The Effects of Herkinorin, the First ??-Selective Ligand from a Salvinorin A-Derived Scaffold, in a Neuroendocrine Biomarker Assay in Nonhuman Primates, Journal of Pharmacology and Experimental Therapeutics, vol.327, issue.1, pp.154-160, 2008.
DOI : 10.1124/jpet.108.140079

E. Butelman, T. Prisinzano, and H. Deng, Unconditioned behavioral effects of the powerful kappa-opioid hallucinogen salvinorin A in nonhuman primates: fast onset and entry into cerebrospinal fluid, J Pharmacol Exp Ther, issue.2, pp.328-588, 2009.

D. Su, J. Riley, W. Kiessling, W. Armstead, and R. Liu, Salvinorin A Produces Cerebrovasodilation through Activation of Nitric Oxide Synthase, ?? Receptor, and Adenosine Triphosphate???sensitive Potassium Channel, Anesthesiology, vol.114, issue.2, pp.374-383, 2011.
DOI : 10.1097/ALN.0b013e318204e029

M. De-chiaro, L. Luongo, K. Jordan, S. Zjawiony, A. A. Maione et al., Ultrapotent effects of salvinorin A, a hallucinogenic compound from Salvia divinorum, on LPSstimulated murine macrophages and its anti-inflammatory action in vivo, J Mol Med, vol.75, 2011.

D. Braida, V. Limonta, and V. Capurro, Involvement of ??-Opioid and Endocannabinoid System on Salvinorin A-Induced Reward, Biological Psychiatry, vol.63, issue.3, pp.286-292, 2008.
DOI : 10.1016/j.biopsych.2007.07.020

S. Inan, D. Lee, and L. Liu-chen, Comparison of the Diuretic Effects of Chemically Diverse